EUVIMEDEUVIMED entdecken
Crossref

Lin28A Drives hepatic fibrosis by suppressing HMGA2/HIF-1α-Dependent ferroptosis in hepatic stellate cells

Ankang Wang, Hongfa Sun, Haixia Zhao, Ye Xie, Mengchao Yan, Yue Zhang, Xiaojing Song, Fanghui Ding, Changpeng Chai, Haixu Ni, Jia Yao, Xun Li

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2026.117900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Ankang Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, PR China. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Ferroptosis, Hepatic Stellate Cells, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province, China International Medical Foundation, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Effective therapies for liver fibrosis are lacking. The RNA-binding protein Lin28A is upregulated in human cirrhotic and mouse fibrotic livers, where it localizes to activated hepatic stellate cells (HSCs). HSCs-specific overexpression of Lin28A worsened carbon tetrachloride (CCl4)-induced fibrosis in mice. In LX-2 and primary mouse HSCs, Lin28A knockdown suppressed activation and induced hallmarks of ferroptosis, including mitochondrial damage, lipid peroxidation, and glutathione depletion. Mechanistically, Lin28A repressed the maturation of let-7 microRNAs, leading to increased expression of its target, high-mobility group AT-hook 2 (HMGA2). HMGA2, alongside hypoxia-inducible factor-1α (HIF-1α), contributed to the downregulation of the ferroptosis defense proteins SLC7A11 and GPX4. Notably, the anti-fibrotic effects of the Lin28A inhibitor C1632 were dependent on ferroptosis induction, as co-treatment with ferrostatin-1 reversed its impact on HSCS activation and death. In vivo, C1632 treatment alleviated CCl4-induced liver fibrosis. These results identify Lin28A as a regulator of HSCS ferroptosis and a potential target for anti-fibrotic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Binding ProteinsFerroptosisHepatic Stellate CellsLiver CirrhosisHMGA2 ProteinHypoxia-Inducible Factor 1, alpha SubunitAnimalsMiceHumansMaleMice, Inbred C57BLCarbon TetrachlorideMicroRNAs

Stichwörter der Autor:innen

FerroptosisHIF-1αHMGA2Hepatic stellate cellsLin28ALiver fibrosis

Substanzen

RNA-Binding ProteinsHMGA2 ProteinLin-28 protein, mouseHypoxia-Inducible Factor 1, alpha SubunitCarbon TetrachlorideHif1a protein, mouseMicroRNAs

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, PR China.
  • The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, PR China; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, PR China; Key Laboratory of Biotherapy and Re…
  • Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, PR China.
  • The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, PR China; Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, Lanzhou 730000, PR China. Electronic address: yaoj06@lzu.edu…

Förderung

  • Natural Science Foundation of Sichuan Province
  • China International Medical Foundation
  • National Key Research and Development Program of China
  • Sichuan Province Department of Science and Technology
  • National Natural Science Foundation of China

Zitieren

APA

Wang, A., Sun, H., Zhao, H., Xie, Y., Yan, M., Zhang, Y., Song, X., Ding, F., Chai, C., Ni, H., Yao, J., & Li, X. (2026). Lin28A Drives hepatic fibrosis by suppressing HMGA2/HIF-1α-Dependent ferroptosis in hepatic stellate cells. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.117900

Vancouver

Wang A, Sun H, Zhao H, Xie Y, Yan M, Zhang Y, et al. Lin28A Drives hepatic fibrosis by suppressing HMGA2/HIF-1α-Dependent ferroptosis in hepatic stellate cells. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.117900

BibTeX
@article{Wang2026,
  author = {Wang, Ankang and Sun, Hongfa and Zhao, Haixia and Xie, Ye and Yan, Mengchao and Zhang, Yue and Song, Xiaojing and Ding, Fanghui and Chai, Changpeng and Ni, Haixu and Yao, Jia and Li, Xun},
  title = {Lin28A Drives hepatic fibrosis by suppressing HMGA2/HIF-1α-Dependent ferroptosis in hepatic stellate cells},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2026.117900}
}
Kostenlos starten →